Brexit: rumors and realities for pharmaceuticals; expert opinion

The UK government has committed to renegotiate its membership of the European Union and to giving the UK electorate the chance, in a referendum, to choose between the revised membership terms or “Brexit.”

The UK government recently concluded negotiations concerning EU membership at an EU Summit. Following these negotiations the Brexit referendum will be held on 23 June 2016, commented Hogan Lovells, the international law firm, in a note on Brexit rumors and realities pharmaceutical and medical device companies have to consider.

The precise impact of a vote for Brexit is uncertain. It would fundamentally change the nature of the UK’s relationship with the rest of the EU and the wider world and may also result in significant changes for those doing business in the UK. These changes may be particularly relevant to the pharmaceutical and medical device industries.